Search for a doctor

Debra A. Bell, M.D.

Request an Appointment

Publications

  1. Michal M, Agaimy A, Croce S, Mechtersheimer G, Gross JM, Xing D, Bell DA, Gupta S, Mosaieby E, Martinek P, Klubickova N, Michalova K, Bouda J, Finek J, Hernandez T, Michal M, Schoolmeester JK, Ondic O. PLAG1-Rearranged Uterine Sarcomas: A Study of 11 Cases Showing a Wide Phenotypical Spectrum Not Limited to Myxoid Leiomyosarcoma-Like Morphology. Mod Pathol. 2024 Sep; 37 (9):100552 Epub 2024 June 26
    View PubMed
  2. Flotte TJ, Derauf SA, Byrd RK, Kroneman TN, Bell DA, Stetzik L, Lee SY, Samiei A, Hart SN, Garcia JJ, Beamer G, Westerling-Bui T. Democratizing Artificial Intelligence in Anatomic Pathology. Arch Pathol Lab Med. 2024 Apr 23 [Epub ahead of print]
    View PubMed
  3. Tora R, Welch J, Sun J, Agarwal SK, Bell DA, Merino M, Weinstein LS, Simonds WF, Jha S. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome. J Clin Endocrinol Metab. 2023 Nov 17; 108 (12):3165-3177
    View PubMed
  4. Swanson AA, Huang Y, Bell DA, Schoolmeester JK. Uterine Endometrial Stromal Tumors With Limited Infiltration and Unusual Patterns of Smooth Muscle/Leiomyomatous Differentiation: A Report of 2 Cases Recapitulating Leiomyoma Variants. Int J Gynecol Pathol 2022 Jul 1; 41 (4):e8-e10 Epub 2021 June 23
    View PubMed
  5. Zarei S, Voss JS, Jin L, Jenkins SM, Bryce AH, Erickson LA, Bell DA, Kipp BR, Flotte TJ. Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site. Int J Gynecol Pathol. 2020 Nov; 39 (6):587-594
    View PubMed
  6. Zarei S, Wang Y, Jenkins SM, Voss JS, Kerr SE, Bell DA. Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma. Am J Surg Pathol. 2020 Mar; 44 (3):316-328
    View PubMed
  7. Binzer-Panchal A, Hardell E, Viklund B, Ghaderi M, Bosse T, Nucci MR, Lee CH, Hollfelder N, Corcoran P, Gonzalez-Molina J, Moyano-Galceran L, Bell DA, Schoolmeester JK, Masback A, Kristensen GB, Davidson B, Lehti K, Isaksson A, Carlson JW. Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes. Clin Cancer Res. 2019 Apr 1; 25 (7):2155-2165 Epub 2019 Jan 07
    View PubMed
  8. Lin S, Wang C, Zarei S, Bell DA, Kerr SE, Runger GC, Kocher JA. A data science approach for the classification of low-grade and high-grade ovarian serous carcinomas. BMC Genomics. 2018 Nov 27; 19 (1):841
    View PubMed
  9. Kocher JP, Sun Q, Wu Y, Miller M, Zhang W, Wang J, Zhang J, Wong T, Lee S, Zhao F, Anderson ML, Brat DJ, Olson JJ, Sica G, Ahn K, Bell D, Borad M, Bryce AH, Castle E, Chandan V, Cheville J, Copland JA, Farnell M, Flotte T, Giama N, Ho T, Nagorney D, O'Brien D, O'Neill BP, Patel T, Petersen G, Que F, Rivera M, Roberts L, Smallridge R, Smyrk T, Stanton M, Thompson RH, Torbenson M, Zhang L, Guo C, Haydu L, Quinn M, Dhanasekaran R, Nguyen P, Peterson L, Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Monnat RJ Jr, Xiao Y, Wang C, Cancer Genome Atlas Research Network. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018 Apr 3; 23 (1):239-254.e6
    View PubMed
  10. Hardell E, Josefson S, Ghaderi M, Skeie-Jensen T, Westbom-Fremer S, Cheek EH, Bell D, Selling J, Schoolmeester JK, Masback A, Davidson B, Carlson JW. Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas. Am J Surg Pathol. 2017 Sep; 41 (9):1231-1237
    View PubMed
  11. Chen L, Butler KA, Bell DA. Fine needle aspiration cytology of cervical lymph node involvement by ovarian serous borderline tumor. Cytojournal. 2016; 13:16 Epub 2016 July 27
    View PubMed
  12. Chien J, Sicotte H, Fan JB, Humphray S, Cunningham JM, Kalli KR, Oberg AL, Hart SN, Li Y, Davila JI, Baheti S, Wang C, Dietmann S, Atkinson EJ, Asmann YW, Bell DA, Ota T, Tarabishy Y, Kuang R, Bibikova M, Cheetham RK, Grocock RJ, Swisher EM, Peden J, Bentley D, Kocher JP, Kaufmann SH, Hartmann LC, Shridhar V, Goode EL. TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer. Nucleic Acids Res. 2015 Aug 18; 43 (14):6945-58 Epub 2015 Apr 27
    View PubMed
  13. Sciallis AP, Bedroske PP, Schoolmeester JK, Sukov WR, Keeney GL, Hodge JC, Bell DA. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol. 2014 Sep; 38(9):1161-72.
    View PubMed
  14. Bell DA. Low-grade serous tumors of ovary. Int J Gynecol Pathol. 2014 Jul; 33 (4):348-56
    View PubMed
  15. Leonard B, Hart SN, Burns MB, Carpenter MA, Temiz NA, Rathore A, Vogel RI, Nikas JB, Law EK, Brown WL, Li Y, Zhang Y, Maurer MJ, Oberg AL, Cunningham JM, Shridhar V, Bell DA, April C, Bentley D, Bibikova M, Cheetham RK, Fan JB, Grocock R, Humphray S, Kingsbury Z, Peden J, Chien J, Swisher EM, Hartmann LC, Kalli KR, Goode EL, Sicotte H, Kaufmann SH, Harris RS. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Res. 2013 Dec 15; 73 (24):7222-31 Epub 2013 Oct 23
    View PubMed
  16. Kerr SE, Flotte AB, McFalls MJ, Vrana JA, Halling KC, Bell DA. Matching maternal isodisomy in mucinous carcinomas and associated ovarian teratomas provides evidence of germ cell derivation for some mucinous ovarian tumors. Am J Surg Pathol. 2013 Aug; 37(8):1229-35.
    View PubMed
  17. Fuehrer NE, Keeney GL, Ketterling RP, Knudson RA, Bell DA. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. Arch Pathol Lab Med. 2012 Jun; 136 (6):623-6
    View PubMed
  18. Medeiros F, Araujo AR, Erickson-Johnson MR, Kashyap PC, Dal Cin P, Nucci M, Wang X, Bell DA, Oliveira AM. HMGA1 and HMGA2 rearrangements in mass-forming endometriosis. Genes Chromosomes Cancer. 2010 Jul; 49 (7):630-4
    View PubMed
  19. Medeiros F, Bell DA. Pseudoneoplastic lesions of the female genital tract. Arch Pathol Lab Med. 2010 Mar; 134 (3):393-403
    View PubMed
  20. Sciallis AP, Aubry MC, Bell DA. Ciliated adenocarcinoma of the ovary with evidence of serous differentiation: report of a case. Int J Gynecol Pathol. 2009 Sep; 28(5):447-52.
    View PubMed
  21. Chien J, Fan JB, Bell DA, April C, Klotzle B, Ota T, Lingle WL, Gonzalez Bosquet J, Shridhar V, Hartmann LC. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecol Oncol. 2009 Jul; 114 (1):3-11 Epub 2009 May 01
    View PubMed
  22. Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. J Cell Biochem. 2007 Dec 1; 102(5):1117-29.
    View PubMed
  23. Misdraji J, Vaidya A, Tambouret RH, Duska L, Bell DA. Psammoma bodies in cervicovaginal cytology specimens: a clinicopathological analysis of 31 cases. Gynecol Oncol. 2006 Oct; 103(1):238-46. Epub 2006 Apr 19.
    View PubMed
  24. Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res. 2006 Sep 1; 12(17):5055-63.
    View PubMed
  25. Rollins SE, Young RH, Bell DA. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol. 2006 Apr; 30(4):457-62.
    View PubMed
  26. Feltmate CM, Lee KR, Johnson M, Schorge JO, Wong KK, Hao K, Welch WR, Bell DA, Berkowitz RS, Mok SC. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Clin Cancer Res. 2005 Nov 1; 11(21):7651-7.
    View PubMed
  27. Rabban JT, Bell DA. Current issues in the pathology of ovarian cancer. J Reprod Med. 2005 Jun; 50(6):467-74.
    View PubMed
  28. Bell DA. Origins and molecular pathology of ovarian cancer. Mod Pathol. 2005 Feb; 18 Suppl 2:S19-32.
    View PubMed
  29. Penson RT, Sahani D, Bell DA. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-2004. A 52-year-old woman with postmenopausal bleeding and a cystic ovarian mass. N Engl J Med. 2004 Dec 9; 351(24):2531-8.
    View PubMed
  30. Bell DA, Longacre TA, Prat J, Kohn EC, Soslow RA, Ellenson LH, Malpica A, Stoler MH, Kurman RJ. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol. 2004 Aug; 35(8):934-48.
    View PubMed
  31. Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, Copeland L, Silva E, Gorstein F, Young RH. Borderline ovarian tumors: key points and workshop summary. Hum Pathol. 2004 Aug; 35(8):910-7.
    View PubMed
  32. Szyfelbein WM, Baker PM, Bell DA. Superficial endometriosis of the cervix: A source of abnormal glandular cells on cervicovaginal smears. Diagn Cytopathol. 2004 Feb; 30(2):88-91.
    View PubMed
  33. Brogi E, Tambouret R, Bell DA. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Cancer. 2002 Apr 25; 96(2):60-6.
    View PubMed
  34. Weir MM, Bell DA. Cytologic identification of serous neoplasms in peritoneal fluids. Cancer. 2001 Oct 25; 93(5):309-18.
  35. Wang VW, Bell DA, Berkowitz RS, Mok SC. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res. 2001 May 15; 61(10):4169-74.
  36. Tambouret R, Bell DA, Centeno BA. Significance of histiocytes in cervical smears from peri/postmenopausal women. Diagn Cytopathol. 2001 Apr; 24(4):271-5.
    View PubMed
  37. Huang LW, Garrett AP, Schorge JO, Muto MG, Bell DA, Welch WR, Berkowitz RS, Mok SC. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum. Am J Clin Pathol. 2000 Jul; 114(1):93-9.
    View PubMed
  38. Huang LW, Garrett AP, Bell DA, Welch WR, Berkowitz RS, Mok SC. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gynecol Oncol. 2000 Jun; 77(3):369-76.
    View PubMed
  39. Houck K, Nikrui N, Duska L, Chang Y, Fuller AF, Bell D, Goodman A. Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol. 2000 Jun; 95(6 Pt 1):839-43.
    View PubMed
  40. Garrett AP, Ng SW, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Apr; 77(1):105-11.
    View PubMed
  41. Tambouret R, Bell DA, Young RH. Microcystic endocervical adenocarcinomas: a report of eight cases. Am J Surg Pathol. 2000 Mar; 24(3):369-74.
    View PubMed
  42. Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res. 2000 Mar 1; 60(5):1361-4.
    View PubMed
  43. Huang LW, Garrett AP, Muto MG, Colitti CV, Bell DA, Welch WR, Berkowitz RS, Mok SC. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol. 2000 Mar; 31(3):367-73.
    View PubMed
  44. Chan WY, Cheung KK, Schorge JO, Huang LW, Welch WR, Bell DA, Berkowitz RS, Mok SC. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol. 2000 Feb; 156(2):409-17.
    View PubMed
  45. Weir MM, Rosenberg AE, Bell DA. Grading of spindle cell sarcomas in fine-needle aspiration biopsy specimens. Am J Clin Pathol. 1999 Dec; 112(6):784-90.
  46. Baker PM, Clement PB, Bell DA, Young RH. Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ. Int J Gynecol Pathol. 1999 Jul; 18(3):198-205.
    View PubMed
  47. Eichhorn JH, Bell DA, Young RH, Scully RE. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol. 1999 Apr; 23(4):397-409.
    View PubMed
  48. Iyengar TD, Ng S, Lau CC, Welch WR, Bell DA, Berkowitz RS, Mok SC. Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors. Oncogene. 1999 Jan 7; 18(1):257-62.
    View PubMed
  49. Tambouret R, Pitman MB, Bell DA. Benign glandular cells in posthysterectomy vaginal smears. Acta Cytol. 1998 Nov-Dec; 42(6):1403-8.
    View PubMed
  50. Weir MM, Bell DA, Young RH. Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors. Am J Surg Pathol. 1998 Jul; 22(7):849-62.
  51. Schorge JO, Muto MG, Welch WR, Bandera CA, Rubin SC, Bell DA, Berkowitz RS, Mok SC. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 1998 Jun 3; 90(11):841-5.
    View PubMed
  52. Lu KH, Bell DA, Welch WR, Berkowitz RS, Mok SC. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998 Jun 1; 58(11):2328-30.
    View PubMed
  53. Weir MM, Bell DA. Transitional cell metaplasia of the cervix: a newly described entity in cervicovaginal smears. Diagn Cytopathol. 1998 Mar; 18(3):222-6.
  54. Edelson MI, Lau CC, Colitti CV, Welch WR, Bell DA, Berkowitz RS, Mok SC. A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors. Oncogene. 1998 Jan 15; 16(2):197-202.
    View PubMed
  55. Edelson MI, Scherer SW, Tsui LC, Welch WR, Bell DA, Berkowitz RS, Mok SC. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Oncogene. 1997 Jun 19; 14(24):2979-84.
    View PubMed
  56. Weir MM, Bell DA, Young RH. Transitional cell metaplasia of the uterine cervix and vagina: an underrecognized lesion that may be confused with high-grade dysplasia. A report of 59 cases. Am J Surg Pathol. 1997 May; 21(5):510-7.
  57. Bell DA. Current controversy: nomenclature of borderline epithelial tumors of the ovary. Pathol Case Reviews. 1997; 2:144-53.
  58. Tangir J, Loughridge NS, Berkowitz RS, Muto MG, Bell DA, Welch WR, Mok SC. Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res. 1996 Jun 1; 56(11):2501-5.
    View PubMed
  59. Young RH, Bell DA, Clement PB. Recent advances in the pathology of ovarian tumors. Mod Pathol. 1995 Dec; 8(9):930-59.
  60. Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS, Mok SC. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene. 1995 Oct 5; 11(7):1249-54.
    View PubMed
  61. Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS, Mok SC. Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res. 1995 May 15; 55(10):2169-72.
    View PubMed
  62. Kupryjanczyk J, Bell DA, Dimeo D, Beauchamp R, Thor AD, Yandell DW. p53 gene analysis of ovarian borderline tumors and stage I carcinomas. Hum Pathol. 1995 Apr; 26(4):387-92.
    View PubMed
  63. Bell DA. Pseudomyoma peritonei in women. Adv Anatom Pathol. 1995; 2:376-8.
  64. Kupryjanczyk J, Bell DA, Yandell DW, Scully RE, Thor AD. p53 expression in ovarian borderline tumors and stage I carcinomas. Am J Clin Pathol. 1994 Nov; 102(5):671-6.
    View PubMed
  65. Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst. 1994 Oct 19; 86(20):1549-51.
  66. Bell DA, Scully RE. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer. 1994 Apr 1; 73(7):1859-64.
    View PubMed
  67. Gajewski WH, Fuller AF Jr, Pastel-Ley C, Flotte TJ, Bell DA. Prognostic significance of DNA content in epithelial ovarian cancer. Gynecol Oncol. 1994 Apr; 53(1):5-12.
    View PubMed
  68. Goodman A, Bell DA, Rice LW. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma. Gynecol Oncol. 1993 Dec; 51(3):355-61.
    View PubMed
  69. Casey AC, Bell DA, Lage JM, Fuller AF, Nikrui N, Rice LW. Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol. 1993 Sep; 50(3):316-22.
    View PubMed
  70. Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW. p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci U S A. 1993 Jun 1; 90(11):4961-5.
    View PubMed
  71. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 1993 Apr 1; 53(7):1489-92.
    View PubMed
  72. Goff BA, Muntz HG, Bell DA, Wertheim I, Rice LW. Human papillomavirus typing in patients with Papanicolaou smears showing squamous atypia. Gynecol Oncol. 1993 Mar; 48(3):384-8.
    View PubMed
  73. Pastel-Levy C, Bell DA, Rosenberg AE, Preffer F, Colvin RB, Flotte TJ. DNA flow cytometry of epithelioid sarcoma. Cancer. 1992 Dec 15; 70(12):2823-6.
    View PubMed
  74. Muntz HG, Bell DA, Lage JM, Goff BA, Feldman S, Rice LW. Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol. 1992 Dec; 80(6):935-9.
    View PubMed
  75. Eichhorn JH, Bell DA, Young RH, Swymer CM, Flotte TJ, Preffer RI, Scully RE. DNA content and proliferative activity in ovarian small cell carcinomas of the hypercalcemic type. Implications for diagnosis, prognosis, and histogenesis. Am J Clin Pathol. 1992 Dec; 98(6):579-86.
    View PubMed
  76. Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, Bell DA. Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecol Oncol. 1992 Aug; 46(2):226-9.
    View PubMed
  77. Rutgers JL, Bell DA. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types. Mod Pathol. 1992 Jul; 5(4):367-71.
    View PubMed
  78. Harlow BL, Cramer DW, Bell DA, Welch WR. Perineal exposure to talc and ovarian cancer risk. Obstet Gynecol. 1992 Jul; 80(1):19-26.
    View PubMed
  79. Jacoby AF, Young RH, Colvin RB, Flotte TJ, Preffer F, Scully RE, Swymer CM, Bell DA. DNA content in juvenile granulosa cell tumors of the ovary: a study of early- and advanced-stage disease. Gynecol Oncol. 1992 Jul; 46(1):97-103.
    View PubMed
  80. Flotte TJ, Pastel-Levy C, Graeme-Cook F, Preffer F, Bell DA. DNA flow cytometry of primary tumors and their skin metastases. Correlation of DNA histograms. Am J Dermatopathol. 1992 Feb; 14(1):19-23.
    View PubMed
  81. Goff BA, Atanasoff P, Brown E, Muntz HG, Bell DA, Rice LW. Endocervical glandular atypia in Papanicolaou smears. Obstet Gynecol. 1992 Jan; 79(1):101-4.
    View PubMed
  82. Bell DA. Flow cytometry of ovarian neoplasms. Curr Top Pathol. 1992; 85:337-56.
    View PubMed
  83. Bell DA. Ovarian serous cystadenoma of borderline malignancy with stromal microinvasion. (No. AP 92-1.) American Society of Clinical Pathology Anatomic Pathologists Check Sample. 1992; 1:1-4.
  84. Harlow BL, Cramer DW, Geller J, Willett WC, Bell DA, Welch WR. The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol. 1991 Sep 1; 134(5):445-53.
    View PubMed
  85. Bell DA. Ovarian surface epithelial-stromal tumors. Hum Pathol. 1991 Aug; 22(8):750-62.
    View PubMed
  86. Pastel-Levy C, Flotte TJ, Preffer F, Ware A, Graeme-Cook F, Bell DA, Colvin RB. Application of DNA flow cytometry from paraffin-embedded tissue to the diagnosis of mycosis fungoides. J Cutan Pathol. 1991 Aug; 18(4):279-83.
    View PubMed
  87. Bell DA. Mucinous adenofibromas of the ovary. A report of 10 cases. Am J Surg Pathol. 1991 Mar; 15(3):227-32.
    View PubMed
  88. Graeme-Cook F, Bell DA, Flotte TJ, Preffer F, Pastel-Levy C, Nardi G, Compton C. Aneuploidy in pancreatic insulinomas does not predict malignancy. Cancer. 1990 Dec 1; 66(11):2365-8.
    View PubMed
  89. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol. 1990 Apr; 21(4):397-403.
    View PubMed
  90. Bell DA, Scully RE. Serous borderline tumors of the peritoneum. Am J Surg Pathol. 1990 Mar; 14(3):230-9.
    View PubMed
  91. Young RH, Bell DA, Scully RE. Pathology of gynecologic malignancies. Semin Surg Oncol. 1990; 6(6):314-22.
  92. Gilks CB, Bell DA, Scully RE. Serous psammocarcinoma of the ovary and peritoneum. Int J Gynecol Pathol. 1990; 9(2):110-21.
    View PubMed
  93. Flotte TJ, Bell DA. Role of skin lesions in the Salem witchcraft trials. Am J Dermatopathol. 1989 Dec; 11(6):582-7.
    View PubMed
  94. Cramer DW, Harlow BL, Willett WC, Welch WR, Bell DA, Scully RE, Ng WG, Knapp RC. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet. 1989 Jul 8; 2(8654):66-71.
    View PubMed
  95. Kuebler DL, Nikrui N, Bell DA. Cytologic features of endometrial papillary serous carcinoma. Acta Cytol. 1989 Jan-Feb; 33(1):120-6.
    View PubMed
  96. Bell DA, Scully RE. Benign and borderline serous lesions of the peritoneum in women. Pathol Annu. 1989; 24 Pt 2:1-21.
    View PubMed
  97. Wolpert HR, Fuller AF, Bell DA. Primary mucinous carcinoid tumor of the ovary. A case report. Int J Gynecol Pathol. 1989; 8(2):156-62.
  98. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer. 1988 Nov 15; 62(10):2212-22.
    View PubMed
  99. Kuritzkes DR, Rein M, Horowitz S, Droege G, Waldron MA, Bell DA, Fuller AF Jr, Ellman LL, Dickersin GR, Swartz MN, et al. Detached ciliary tufts mistaken for peritoneal parasites: a warning. Rev Infect Dis. 1988 Sep-Oct; 10(5):1044-7.
    View PubMed
  100. Bell DA. Cytologic features of islet-cell tumors. Acta Cytol. 1987 Jul-Aug; 31(4):485-92.
    View PubMed
  101. Bell DA, Flotte TJ, Bhan AK. Immunohistochemical characterization of seminoma and its inflammatory cell infiltrate. Hum Pathol. 1987 May; 18(5):511-20.
    View PubMed
  102. Stone GC, Bell DA, Fuller A, Dickersin GR, Scully RE. Malignant schwannoma of the ovary. Report of a case. Cancer. 1986 Oct 1; 58(7):1575-82.
    View PubMed
  103. Bell DA, Mondschein M, Scully RE. Giant cell arteritis of the female genital tract. A report of three cases. Am J Surg Pathol. 1986 Oct; 10(10):696-701.
    View PubMed
  104. Bell DA, Carr CP, Szyfelbein WM. Fine needle aspiration cytology of focal liver lesions. Results obtained with examination of both cytologic and histologic preparations. Acta Cytol. 1986 Jul-Aug; 30(4):397-402.
    View PubMed
  105. Senekjian EK, Hubby M, Bell DA, Anderson D, Herbst AL. Clear cell adenocarcinoma (CCA) of the vagina and cervix in association with pregnancy. Gynecol Oncol. 1986 Jun; 24(2):207-19.
    View PubMed
  106. Bell DA, Scully RE. Benign and borderline clear cell adenofibromas of the ovary. Cancer. 1985 Dec 15; 56(12):2922-31.
    View PubMed
  107. Bell DA, Shimm DS, Gang DL. Wilms' tumor of the endocervix. Arch Pathol Lab Med. 1985 Apr; 109(4):371-3.
    View PubMed
  108. Bell DA, Scully RE. Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases. Am J Surg Pathol. 1985 Mar; 9(3):205-14.
    View PubMed
  109. Shimm DS, Bell DA, Fuller AF, Bowling MC, Orlow EL, Munzenrider JE, Nelson JH Jr, Ingersoll FM, Nikrui N, Donovan J. Sarcomas of the uterine corpus: prognostic factors and treatment. Radiother Oncol. 1984 Oct; 2(3):201-7.
    View PubMed
  110. Yoshimura S, Scully RE, Bell DA, Taft PD. Correlation of ascitic fluid cytology with histologic findings before and after treatment of ovarian cancer. Am J Obstet Gynecol. 1984 Mar 15; 148(6):716-21.
  111. Bell DA, Woodruff JM, Scully RE. Ependymoma of the broad ligament. A report of two cases. Am J Surg Pathol. 1984 Mar; 8(3):203-9.
    View PubMed
  112. Demopoulos RI, Bell DA. The fine structure of a virilizing human granulosa-theca cell tumor. Observations on the nature of the hormone producing cell. Cancer. 1983 May 15; 51(10):1858-65.
    View PubMed
  113. Bell DA, Hajdu SI, Urban JA, Gaston JP. Role of aspiration cytology in the diagnosis and management of mammary lesions in office practice. Cancer. 1983 Apr 1; 51(7):1182-9.
    View PubMed
  114. Roses DF, Bell DA, Flotte TJ, Taylor R, Ratech H, Dubin N. Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. Am J Clin Pathol. 1982 Dec; 78(6):817-20.
    View PubMed
  115. Bell DA, Flotte TJ. Factor VIII related antigen in adenomatoid tumors: implications for histogenesis. Cancer. 1982 Sep 1; 50(5):932-8.
    View PubMed
  116. Bell DA, Greco MA, Mitnick JS, Genieser NB. Chronic relapsing pancreatitis in childhood. J Pediatr Surg. 1981 Oct; 16(5):741-3.
    View PubMed
  117. Bell DA, Greco MA. Cardiac myxoma with chondroid features: a light and electron microscopic study. Hum Pathol. 1981 Apr; 12(4):370-4.
    View PubMed
  118. Flotte TJ, Bell DA, Sidhu GS, Plair CM. Leiomyosarcoma of the dartos muscle. J Cutan Pathol. 1981 Feb; 8(1):69-74.
    View PubMed
  119. Bell DA, Demopoulos RI. Benign cystic teratoma in the omentum: a mechanism of its development. Diagn Gynecol Obstet. 1980 Fall; 2(3):205-8.
    View PubMed
  120. Flotte TJ, Bell DA, Greco MA. Tubular carcinoma and sclerosing adenosis: the use of basal lamina as a differential feature. Am J Surg Pathol. 1980 Feb; 4(1):75-7.
    View PubMed
PST-20514095